title: Pathophysiological roles and clinical importance of biomarkers in acute coronary syndrome.
abstract: Early diagnosis of acute coronary syndrome (ACS) is important to guide appropriate therapy at a time when it is most likely to be of value. Accurate prognostic and risk stratification will facilitate high-risk patients to have early advanced diagnostic investigations and early appropriate interventions in a cost-effective and efficient manner, while those patients at low risk of ACS complications do not need such costly diagnostic tests and unnecessary hospital admission. Recent investigations have demonstrated that elevation of biomarkers upstream from acute-phase biomarkers, biomarkers of plaque destabilization and rupture, biomarkers of myocardial ischemia, necrosis, and dysfunction may provide an earlier assessment of patient risk and identify patients with higher risk of having an adverse event. This review provides an overview of the pathophysiology and clinical characteristics of several well-established biomarkers as well as emerging biomarkers that may have potential clinical utility in patients with ACS. Such emerging biomarkers hold promise and need to be more thoroughly evaluated before utilization in routine clinical practice.
authors: Accident and Emergency Medicine Academic Unit, Prince of Wales Hospital, The Chinese University of Hong Kong, Sha Tin, NT, Hong Kong SAR, PR China. cangelchan@cuhk.edu.hk
authors: Cangel Pui-Yee
authors: CP
authors: Chan
authors: Timothy Hudson
authors: TH
authors: Rainer
mesh_terms: D054058:Acute Coronary Syndrome / Q000175:diagnosis* / Q000209:etiology; D015415:Biomarkers; D006801:Humans; D007249:Inflammation / Q000175:diagnosis; D017202:Myocardial Ischemia / Q000175:diagnosis / Q000209:etiology; D009206:Myocardium / Q000473:pathology; D009336:Necrosis; D058226:Plaque, Atherosclerotic / Q000175:diagnosis
chemical_list: D015415:Biomarkers